JNJON

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue.

ImeJNJON

PoredakNo.3331

Tržišna kapitalizacija$0,00

Potpuno razrijeđena tržišna kapitalizacija$0,00

Tržišni udio%

Obujam trgovanja / tržišna kapitalizacija (24-satni)%743.256,89

Količina u optjecaju128,5796356

Maksimalna količina0

Ukupna količina128,5796356

Stopa optjecaja%

Datum izdavanja--

Cijena po kojoj je imovina prvi put izdana--

Najviša vrijednost svih vremena250.607309426007,2026-03-02

Najniža cijena203.9667432969526,2026-01-09

Javni blockchainETH

UvodJohnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue.

Sektor

Društvene mreže

• Službena web-stranica
• Blokiraj pretraživač

etfindex:mc_etfindex_sourceOdricanje od odgovornosti: Podatke pruža cmc i ne smiju se smatrati investicijskim savjetom.